

Regenerative medicine information
MSC exosomes, explained with sources and without the hype
Learn what mesenchymal stromal cell (MSC) exosomes are, what published research shows so far, and how FDA regulates these products before you make any decision.
- Every claim cited to PubMed, DOI or fda.gov
- No products sold and no clinic referrals
- Free, educational and independent
What are MSC exosomes?
Exosomes are tiny particles, roughly 30 to 150 nanometers across, that cells release into their surroundings. Scientists group them with other extracellular vesicles (EVs). They carry proteins, lipids and genetic material such as RNA, and researchers study them as a way cells signal to each other.
MSC exosomes are vesicles collected from mesenchymal stromal cells grown in a laboratory. International research groups have published standards for how these cells and vesicles should be defined and reported, because products sold under the same name can differ widely.
Source cells
MSCs are defined by lab criteria such as growth on plastic, specific surface markers and the ability to form bone, fat and cartilage cells in a dish.
What is inside
Vesicle contents depend on the donor, cell culture conditions and how the vesicles are isolated, which is why standard reporting matters.
Why it matters
Without consistent characterization, two products with the same label may not contain the same thing. Ask for testing data, not marketing claims.



Current research status
Bottom line: MSC exosome research is active but early. FDA has not approved any exosome product to treat any disease. Laboratory and animal results do not show that a product is safe or effective in people.
Laboratory and animal studies
Most published work is preclinical. It helps researchers form hypotheses, but many findings do not carry over to humans.
Early clinical studies
Some small early-phase studies are registered. Their main goal is usually safety and dosing, not proof that something works.
Topic summaries
Read our source lists for brain injury, COPD and knee osteoarthritis research, and how FDA pathways apply.
Patents and published applications
Patent documents related to exosome compositions and stabilization, listed with their public Google Patents records. See the patents page for the same list on its own page.
Note: Published applications are not issued patents. Listings describe patent documents only. They are not evidence that any product is safe, effective or FDA approved.
Exosome systems, products and methods
Publication date:
Inventors: Babak Ghalili, Keyon Janani, Peter Scherp, John Borja
Google Patents legal status: PendingExosome systems, products and methods
Publication date:
Inventors: Babak Ghalili, Craig M Siegler, Keyon Janani, Peter Scherp, John Borja
Google Patents legal status: AbandonedExosome systems, products and methods
Publication date:
Inventors: Babak Ghalili, Keyon Janani, Peter Scherp, John Borja
Google Patents legal status: PendingExosome systems, products and methods
Publication date:
Inventors: Babak Ghalili, Craig M Siegler, Keyon JANANI, Peter SCHERP, John Borja
Google Patents legal status: CeasedExosome bone graft systems, products and methods
Grant date:
Inventors: Ghalili Babak, Janani Keyon, Scherp Peter, Borja John
Google Patents legal status: ActivePolymer-polymer Matrix for the Stabilization of Exosomes
Publication date:
Inventors: Babak Ghalili, Keyon Janani, Michael J. Borja
Google Patents legal status: PendingPolymer-polymer matrix for the stabilization of exosomes
Publication date:
Inventors: Babak Ghalili, Keyon Janani, Michael J. Borja
Google Patents legal status: Pending
Details verified on Google Patents on 2026-10-16. Status and dates can change, so check the linked record for the latest information.
Why you can trust this information
Educational only
This site is not a clinic, a seller or a medical provider. It does not recommend any product, provider or treatment.
Primary sources
Regulatory statements link to fda.gov. Scientific statements link to peer-reviewed papers with PMID or DOI.
Privacy note
We use your details only to send the information you ask for. We do not sell or share them, and we never ask for medical records. Ask us to delete your details at any time by replying to any email.
Key sources
- Welsh JA, et al. Minimal information for studies of extracellular vesicles (MISEV2023). J Extracell Vesicles. 2024. PMID 38326288, DOI 10.1002/jev2.12404.
- Théry C, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018). J Extracell Vesicles. 2018. PMID 30637094, DOI 10.1080/20013078.2018.1535750.
- Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. Cytotherapy. 2006. PMID 16923606, DOI 10.1080/14653240600855905.
- U.S. FDA. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes.
- U.S. FDA. Public Safety Notification on Exosome Products.
Frequently asked questions
What are MSC exosomes?
Exosomes are tiny membrane-bound particles, a type of extracellular vesicle, that cells release. MSC exosomes are vesicles collected from mesenchymal stromal cells grown in a lab. They carry proteins, lipids and RNA, and researchers are studying how they signal to other cells.
Are exosome products FDA approved?
No. FDA has not approved any exosome product to treat any disease or condition. FDA has issued consumer alerts and safety notifications warning about unapproved stem cell and exosome products marketed to patients.
Is MSC exosome research the same as an available treatment?
No. Most published work is laboratory, animal or early-stage clinical research. Research results do not mean a product is safe or effective for any person, and they are not a reason to buy or receive a product.
What does Research Use Only mean?
A Research Use Only label is meant for laboratory research. It is not FDA approval, and it does not make a product lawful to give to patients.
What happens when I request information?
You receive educational resources about how FDA regulates regenerative medicine products and what the published research says. This site does not sell products, refer patients to clinics or give medical advice.
Who should I talk to about my health?
A licensed physician who knows your medical history. You can also check ClinicalTrials.gov for registered clinical studies and discuss any study with your doctor before enrolling.
Get the facts before you decide
Request free educational resources on MSC exosome research, FDA rules and how to spot red flags in product marketing.
Important: Exosome products are not FDA approved to treat any disease or condition. This site provides education only, not medical advice, and makes no claim that any product cures or treats anything. Read FDA's consumer alert and talk with a licensed physician.